Presentation is loading. Please wait.

Presentation is loading. Please wait.

Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study  S. Rhedin, I. Galanis, F. Granath,

Similar presentations


Presentation on theme: "Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study  S. Rhedin, I. Galanis, F. Granath,"— Presentation transcript:

1 Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study  S. Rhedin, I. Galanis, F. Granath, A. Ternhag, J. Hedlund, C. Spindler, P. Naucler  Clinical Microbiology and Infection  Volume 23, Issue 4, Pages (April 2017) DOI: /j.cmi Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2 Fig. 1 Flowchart of study subjects. BSBM, broad-spectrum ß-lactam monotherapy (cephalosporin or piperacillin/tazobactam); CAP, community-acquired pneumonia; NSBM, narrow-spectrum ß-lactam monotherapy (benzylpenicillin or phenoxymethylpenicillin). Other treatment, any other antibiotic treatment regimens (see Table S2, supporting information, for details). Clinical Microbiology and Infection  , DOI: ( /j.cmi ) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions


Download ppt "Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study  S. Rhedin, I. Galanis, F. Granath,"

Similar presentations


Ads by Google